Prescriptions for off-label medications; terms; moral, ethical, or religious exemptions; immunity from liability; good- faith effort; temporary privileges; at-home and outpatient dispensing; disciplinary action; exceptions; World Health Organization; effective date.

HB 1344 allows doctors to prescribe medications for uses not approved by the FDA (off-label) after obtaining a patient's informed consent, without requiring prior test results or exposure to the condition. It requires prescribers to explain treatment options, risks, and benefits to patients or their representatives before issuing such prescriptions. Pharmacists and hospitals must dispense off-label drugs unless they have a documented moral, ethical, religious objection or a life-threatening allergy history, and providers are protected from liability if they document scientific objections to specific dosages. The bill directly affects patients, doctors, pharmacists, and hospitals by clarifying dispensing rules, reducing administrative barriers, and providing legal safeguards for off-label prescribing.